← Eichor
Condition: Hemophilia B Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hemophilia B

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265)
Phase 1/Phase 2 · 44 location(s) · Regeneron Pharmaceuticals · NCT06379789World Bleeding Disorders Registry
Phase N/A · 1 location(s) · World Federation of Hemophilia · NCT03327779The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05630651Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Ade
Phase 3 · 30 location(s) · CSL Behring · NCT06003387Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · 12 location(s) · CSL Behring · NCT07080905Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B R
Phase 3 · 23 location(s) · Pfizer · NCT05568719Liver Biopsy In Haemophilia Gene Therapy
NA · 1 location(s) · University College, London · NCT04817462A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Phase 3 · 2 location(s) · Emory University · NCT04563520Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
Phase 4 · 1 location(s) · Konkuk University Medical Center · NCT06144125A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · 30 location(s) · Sanofi · NCT07285460The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With
Phase 3 · 14 location(s) · Biocad · NCT06700096National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05641610Lentiviral FIX Gene Therapy
Phase 1 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03961243Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
Phase 1/Phase 2 · 17 location(s) · Biocad · NCT06120582Measurement Properties in People with Hemophilia
NA · 1 location(s) · University of Zurich · NCT06565481Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Phase 3 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT07545395ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic
Phase 1/Phase 2 · 9 location(s) · Shanghai RAAS Blood Products Co., Ltd. · NCT07644832ATHNdataset Registry
Phase N/A · 1 location(s) · American Thrombosis and Hemostasis Network · NCT06820515SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Phase 4 · 21 location(s) · American Thrombosis and Hemostasis Network · NCT04647227Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05709288German Pediatric Hemophilia Research Database
Phase N/A · 1 location(s) · Goethe University · NCT02912143A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Phase N/A · 12 location(s) · CSL Behring · NCT06008938Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.